Mail

UK markets closed

FTSE 100
8,225.33
-22.46(-0.27%)
FTSE 250
20,298.10
-65.33(-0.32%)
AIM
766.05
-1.98(-0.26%)
GBP/EUR
1.1816
-0.0022(-0.19%)
GBP/USD
1.2627
-0.0060(-0.47%)
Bitcoin GBP
48,639.48
-331.06(-0.68%)

The cost of following England at Euro 2024

What could your money earn if you invested your football spending elsewhere

Raily Aesthetic Medicine International Holdings Limited (2135.HK)

HKSE - HKSE Delayed price. Currency in HKD

Add to watchlist

0.123

0.000

(0.00%)

At close: 02:53PM HKT

Currency in HKD

Valuation measures⁴

Market cap (intra-day)	68.52M
Enterprise value	81.41M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	0.06
Price/book (mrq)	0.46
Enterprise value/revenue	0.40
Enterprise value/EBITDA	52.89

Trading information

Stock price history

Beta (5Y monthly)	1.09
52-week change ³	-79.19%
S&P500 52-week change ³	24.96%
52-week high ³	0.674
52-week low ³	0.123
50-day moving average ³	0.147
200-day moving average ³	0.350

Share statistics

Avg vol (3-month) ³	435.63k
Avg vol (10-day) ³	100.52k
Shares outstanding ⁵	557.08M
Implied shares outstanding ⁶	557.08M
Float ⁸	125.15M
% held by insiders ¹	66.02%
% held by institutions ¹	4.03%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	1:5
Last split date ³	19 Mar 2024

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	-17.14%
Operating margin (ttm)	-22.02%

Management effectiveness

Return on assets (ttm)	-4.88%
Return on equity (ttm)	-25.32%

Income statement

Revenue (ttm)	189.38M
Revenue per share (ttm)	0.45
Quarterly revenue growth (yoy)	30.90%
Gross profit (ttm)	N/A
EBITDA	-7M
Net income avi to common (ttm)	-32.46M
Diluted EPS (ttm)	-0.360
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	39.79M
Total cash per share (mrq)	0.09
Total debt (mrq)	51.78M
Total debt/equity (mrq)	39.06%
Current ratio (mrq)	0.86
Book value per share (mrq)	0.33

Cash flow statement

Operating cash flow (ttm)	8.02M
Levered free cash flow (ttm)	2.87M